ADMA BIOLOGICS, INC. ADMA Income Statement

Adma biologics, inc. (ADMA)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
REVENUES:
Product revenue
35,877	29,206	21,225	18,233	16,329	16,842	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Product revenue
-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
License revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	160	144	127	87	75	75	75	75	75	62	44	25	0	0	-	0	-	-	-	-	-	-	-	-
License and other revenue
0	-	0	0	0	-	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License and other revenue
-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Other revenue
-	-	-	-	-	142	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Revenues
36,020	29,349	21,368	18,376	16,471	16,985	24,931	25,430	24,173	22,760	14,085	12,293	11,166	10,661	9,845	8,760	7,798	7,177	6,154	5,667	5,858	5,915	4,850	4,592	3,835	3,067	3,166	2,419	1,906	1,118	1,355	995	765	761	0	0	0	-	-
Total Revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-
OPERATING EXPENSES
Cost of product revenue (exclusive of amortization expense shown below)
46,928	39,504	38,954	40,202	39,357	42,194	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of product revenue (exclusive of amortization expense shown below)
-	-	-	-	-	-	-	-	-	-	-	-	6,710	6,360	5,849	5,226	4,668	4,311	3,765	3,520	3,674	3,742	3,067	2,926	2,471	2,023	1,885	0	0	-	0	-	0	-	0	0	-	-	-
Cost of product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Gross profit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	-
Research and development
3,001	2,343	2,796	3,307	3,831	3,926	4,213	5,024	5,342	5,570	4,948	4,811	6,853	7,688	9,101	9,535	7,641	7,015	6,938	6,310	6,588	9,517	10,553	10,479	12,165	9,303	7,614	8,146	4,854	3,469	2,404	520	481	646	0	0	0	-	-
Loss on sale of research and development inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Professional fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0
Plasma center operating expenses
2,015	2,169	3,965	5,482	6,626	7,805	7,386	6,996	6,858	6,503	6,052	5,952	5,646	5,447	5,316	5,047	4,850	4,618	4,568	4,372	4,096	3,850	3,346	2,986	2,705	2,418	2,132	1,963	1,802	1,746	1,332	1,293	1,278	1,195	1,192	742	0	0	0
Amortization of intangible assets
812	844	844	844	844	844	1,521	1,584	1,445	1,234	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, general and administrative
28,247	25,910	24,951	23,424	22,777	22,502	22,273	20,799	19,796	18,752	16,192	13,775	11,064	8,494	7,095	7,394	7,107	6,745	5,973	4,930	5,035	4,823	4,710	4,520	4,068	4,365	4,062	4,252	3,898	3,142	2,945	2,172	1,749	1,431	0	0	0	-	-
TOTAL OPERATING EXPENSES
81,005	70,773	71,513	73,262	73,436	77,274	79,216	80,351	74,079	62,070	46,795	34,313	30,274	27,991	27,362	27,204	24,268	22,691	21,246	19,133	19,394	21,934	21,678	20,912	21,411	18,110	15,933	15,904	11,754	9,027	6,269	3,428	4,139	4,509	4,506	3,743	0	0	0
LOSS FROM OPERATIONS
-44,985	-41,424	-50,145	-54,886	-56,964	-60,288	-54,284	-54,921	-49,905	-39,309	-32,710	-22,019	-19,108	-17,330	-17,516	-18,444	-16,470	-15,513	-15,092	-13,466	-13,536	-16,018	-16,827	-16,320	-17,576	-15,042	-12,764	-13,482	-9,845	-7,909	-5,790	-3,309	-4,250	-4,622	0	0	0	-	-
OTHER INCOME (EXPENSE):
Interest and other income
921	800	679	472	296	195	157	90	65	57	47	51	55	50	49	48	46	37	31	23	17	14	10	9	8	7	10	14	14	20	0	0	0	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0
Interest expense
10,169	8,993	7,700	6,453	5,740	5,522	5,326	4,707	3,990	3,285	2,672	2,495	2,390	2,239	2,075	1,918	1,834	1,842	1,760	1,646	1,535	1,286	1,072	900	716	618	467	306	150	30	0	0	0	-	-	0	0	-	-
Change in fair value of stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	67	37	23	-11	-74	-61	-44	11	43	60	57	36	0	0	0	0	-	-	-	-	-	-
Loss on extinguishment of debt
0	-9,962	-9,962	-9,962	-9,962	0	0	0	0	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on transfer of plasma center assets
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expense
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	-	-	0	0	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-
Other expense
-	-	-	-	-	-127	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other (expense) income, net
-9,470	-6,854	-5,611	-4,567	-4,024	-5,454	-6,403	-5,834	-5,138	-4,448	-2,624	-2,443	-2,330	-2,184	-2,021	-1,865	-2,506	-2,456	-2,410	-2,318	-1,529	-1,346	-1,123	-934	-613	-484	-313	-152	-99	-9	0	0	0	-	0	0	0	-	-
LOSS BEFORE INCOME TAXES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,918	-6,622	-4,357	-5,538	-6,224	0	0	0	-	-
State income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-617	-617	-617	-617	-320	0	0	0	-	-
NET LOSS
-54,456	-48,279	-55,756	-59,453	-60,989	-65,743	-60,688	-60,755	-55,044	-43,758	-35,335	-24,463	-21,439	-19,515	-19,538	-20,309	-18,976	-17,969	-16,950	-15,232	-14,514	-16,813	-17,951	-17,255	-18,189	-15,527	-13,077	-13,634	-9,945	-7,301	-5,058	-2,793	-3,973	-4,957	-4,953	-3,977	0	0	0
Weighted average number of common shares outstanding - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,500	-	-	-	2,500	2,500
BASIC AND DILUTED LOSS PER COMMON SHARE
-0.26	-0.17	-0.19	-0.25	-0.28	-0.39	-0.33	-0.35	-0.39	-0.26	-0.59	-0.55	-0.51	-0.34	-0.34	-0.50	-0.43	-0.44	-0.48	-0.44	-0.37	-0.38	-0.36	-0.43	-0.64	-0.54	-0.46	-0.83	-0.55	-0.46	-0.55	-0.20	-0.18	0.00	-2.79	-6.79	-4.50	0.00	0.00
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted
73,781	59,515	59,317	52,206	46,353	46,351	46,350	42,712	45,317	36,479	25,790	16,427	12,886	12,894	12,886	12,121	10,710	10,380	10,707	10,705	9,855	9,291	9,291	9,291	9,291	8,511	5,871	5,871	5,871	5,878	5,910	5,910	3,363	-	-	-	-	-	-
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	351	351	351	-	-